{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:27:17Z","timestamp":1782181637899,"version":"3.54.5"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":3474,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1111\/jth.12266","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:19:35Z","timestamp":1372637975000},"page":"180-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"S1","title":["Thrombosis in women: what are the knowledge gaps in 2013?"],"prefix":"10.1016","volume":"11","author":[{"given":"S.","family":"Middeldorp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12266_bb0010","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/jwh.2009.1695","article-title":"Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies","volume":"6","author":"Bairey Merz","year":"2010","journal-title":"J Womens Health"},{"key":"10.1111\/jth.12266_bb0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2796.1992.tb00565.x","article-title":"A prospective study of the incidence of deep\u2010vein thrombosis within a defined urban population","volume":"2","author":"Nordstrom","year":"1992","journal-title":"J Intern Med"},{"key":"10.1111\/jth.12266_bb0020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population\u2010based study","volume":"4","author":"Naess","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0025","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"20","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12266_bb0030","first-page":"957","article-title":"Hormone therapies and venous thromboembolism: where are we now?","volume":"2","author":"van Hylckama Vlieg","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0035","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population\u2010based perspective of the hospital incidence and case\u2010fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study","volume":"5","author":"Anderson","year":"1991","journal-title":"Arch Int Med"},{"key":"10.1111\/jth.12266_bb0040","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2013control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/jth.12266_bb0045","first-page":"321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the Women's Health Initiative randomized controlled trial","volume":"3","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/jth.12266_bb0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"7","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/jth.12266_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8\u00a0years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow\u2010up (HERS II)","volume":"1","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/jth.12266_bb0060","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta\u2010analysis","volume":"7655","author":"Canonico","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/jth.12266_bb0065","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1111\/jth.12266_bb0070","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1182\/blood.V88.11.4205.4205","article-title":"Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients","volume":"11","author":"Lensen","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0075","first-page":"610","article-title":"The value of family history as a risk indicator for venous thrombosis","volume":"6","author":"Bezemer","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.12266_bb0080","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1001\/archinte.164.17.1932","article-title":"Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy\u2010related complications in a family study","volume":"17","author":"Bank","year":"2004","journal-title":"Arch Int Med"},{"key":"10.1111\/jth.12266_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1538-7836.2004.01033.x","article-title":"Elevated levels of FVIII:c within families are associated with an increased risk for venous and arterial thrombosis","volume":"1","author":"Bank","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7326\/0003-4819-128-1-199801010-00003","article-title":"The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis","volume":"1","author":"Middeldorp","year":"1998","journal-title":"Ann Int Med"},{"key":"10.1111\/jth.12266_bb0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1614442","article-title":"The incidence of venous thromboembolism in families with inherited thrombophilia","volume":"2","author":"Simioni","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1055\/s-2007-985753","article-title":"Thrombophilia and venous thromboembolism: implications for testing?","volume":"6","author":"Cohn","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12266_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11239-011-0572-y","article-title":"Evidence\u2010based approach to thrombophilia testing","volume":"3","author":"Middeldorp","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.12266_bb0110","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2011-03-345678","article-title":"Thrombotic risk during oral contraceptive use and pregnancy in women with factor\u2010V\u2010Leiden or prothrombin mutation; a rational approach to contraception","volume":"8","author":"van Vlijmen","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0115","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"19","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/jth.12266_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.1.5901.215","article-title":"Recurrence of venous thromboembolic disease and use of oral contraceptives","volume":"1","author":"Badaracco","year":"1974","journal-title":"Br Med J"},{"key":"10.1111\/jth.12266_bb0125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/jth.12266_bb0130","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","article-title":"The risk of recurrent venous thromboembolism in men and women","volume":"25","author":"Kyrle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12266_bb0135","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1160\/TH09-10-0685","article-title":"Risk of recurrent venous thromboembolism after a first oestrogen\u2010associated episode. Data from the REVERSE cohort study","volume":"3","author":"Le Gal","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0140","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-0037-1614156","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy. Results of the randomized, double\u2010blind, placebo\u2010controlled estrogen in venous thromboembolism trial (EVTET)","volume":"84","author":"Hoibraaten","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0145","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/gme.0b013e3181f9f7c3","article-title":"Hormone therapy and recurrence of venous thromboembolism among postmenopausal women","volume":"5","author":"Olie","year":"2011","journal-title":"Menopause"},{"key":"10.1111\/jth.12266_bb0150","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"5","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/jth.12266_bb0155","first-page":"1","article-title":"Pregnancy\u2010related mortality surveillance\u2013United States, 1991\u20131999","volume":"2","author":"Chang","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1111\/jth.12266_bb0160","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/ejvs.2001.1499","article-title":"A 16\u2010year haemodynamic follow\u2010up of women with pregnancy\u2010related medically treated iliofemoral deep venous thrombosis","volume":"5","author":"Rosfors","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1111\/jth.12266_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002048","article-title":"Long\u2010term impact of pregnancy\u2010related venous thrombosis on quality\u2010of\u2010life, general health and functioning: results of a cross\u2010sectional, case\u2013control study","volume":"2","author":"Wik","year":"2012","journal-title":"BMJ Open"},{"key":"10.1111\/jth.12266_bb0170","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30\u2010year population\u2010based study","volume":"10","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12266_bb0175","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1538-7836.2008.02961.x","article-title":"Ante\u2010 and postnatal risk factors of venous thrombosis: a hospital\u2010based case\u2013control study","volume":"6","author":"Jacobsen","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0180","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"4","author":"Pomp","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006254-199904000-00023","article-title":"Deep vein thrombosis during pregnancy and the puerperium: a meta\u2010analysis of the period of risk and the leg of presentation","volume":"54","author":"Ray","year":"1999","journal-title":"Obstet Gynecol Surv"},{"key":"10.1111\/jth.12266_bb0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-151-2-200907210-00004","article-title":"Predicting deep venous thrombosis in pregnancy: out in \u201cLEFt\u201d field?","volume":"2","author":"Chan","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12266_bb0195","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1538-7836.2010.03783.x","article-title":"D\u2010dimer testing in pregnant patients: towards determining the next \u201clevel\u201d in the diagnosis of DVT","volume":"8","author":"Chan","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0200","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1538-7836.2005.01779.x","article-title":"Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review","volume":"3","author":"Nijkeuter","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1503\/cmaj.091692","article-title":"Anatomic distribution of deep vein thrombosis in pregnancy","volume":"7","author":"Chan","year":"2010","journal-title":"CMAJ"},{"key":"10.1111\/jth.12266_bb0210","doi-asserted-by":"crossref","first-page":"E194","DOI":"10.1503\/cmaj.120895","article-title":"Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging","volume":"4","author":"Chan","year":"2013","journal-title":"CMAJ"},{"key":"10.1111\/jth.12266_bb0215","first-page":"189","article-title":"Risks to the foetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease","volume":"2","author":"Ginsberg","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0220","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1538-7836.2004.00929.x","article-title":"Diagnosing pulmonary embolism in pregnancy: rationalizing foetal radiation exposure in radiological procedures","volume":"10","author":"Nijkeuter","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0225","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2214\/AJR.04.1917","article-title":"Radiation dose to the female breast from 16\u2010MDCT body protocols","volume":"6","author":"Hurwitz","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1111\/jth.12266_bb0230","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.201108-1575ST","article-title":"An official American Thoracic Society\/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy","volume":"10","author":"Leung","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/jth.12266_bb0235","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archinte.162.10.1170","article-title":"Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes","volume":"162","author":"Chan","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.12266_bb0240","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.10100986","article-title":"Pulmonary embolism during pregnancy: diagnosis with lung scintigraphy or CT angiography?","volume":"2","author":"Revel","year":"2011","journal-title":"Radiology"},{"key":"10.1111\/jth.12266_bb0245","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1007\/s00330-007-0607-0","article-title":"Perfusion scintigraphy: diagnostic utility in pregnant women with suspected pulmonary embolic disease","volume":"10","author":"Scarsbrook","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1111\/jth.12266_bb0250","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.2214\/AJR.09.3506","article-title":"Pulmonary embolism in pregnancy: CT pulmonary angiography versus perfusion scanning","volume":"3","author":"Shahir","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1111\/jth.12266_bb0255","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2214\/AJR.09.2360","article-title":"Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy","volume":"5","author":"Ridge","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1111\/jth.12266_bb0260","first-page":"172","article-title":"Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D\u2010dimer testing, and computed tomography","volume":"2","author":"van Belle","year":"2006","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1111\/jth.12266_bb0265","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy and pregnancy: ACCP evidence\u2010based clinical practice guidelines (Ninth Edition)","volume":"2","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"Suppl","key":"10.1111\/jth.12266_bb0270","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence\u2010based clinical practice guidelines","volume":"2","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jth.12266_bb0275","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1378\/chest.130.6.1808","article-title":"Is recurrent venous thromboembolism after therapy reduced by low\u2010molecular\u2010weight heparin compared with oral anticoagulants?","volume":"6","author":"Ferretti","year":"2006","journal-title":"Chest"},{"key":"10.1111\/jth.12266_bb0280","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low\u2010molecular\u2010weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"2","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12266_bb0285","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1182\/blood-2011-04-306589","article-title":"How i treat pregnancy\u2010related venous thromboembolism","volume":"20","author":"Middeldorp","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0290","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2007.06826.x","article-title":"The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey","volume":"4","author":"Voke","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12266_bb0295","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.2007.01622.x","article-title":"Antenatal pulmonary embolism: risk factors, management and outcomes","volume":"4","author":"Knight","year":"2008","journal-title":"BJOG"},{"key":"10.1111\/jth.12266_bb0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AAP.0b013e3181c15c70","article-title":"Regional anaesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence\u2010Based Guidelines (Third Edition)","volume":"1","author":"Horlocker","year":"2010","journal-title":"Reg Anesth Pain Med"},{"key":"10.1111\/jth.12266_bb0305","first-page":"319","article-title":"Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women","volume":"2","author":"Conard","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0310","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-125-12-199612150-00003","article-title":"Frequency of pregnancy\u2010related venous thromboembolism in anticoagulant factor\u2010deficient women: implications for prophylaxis","volume":"125","author":"Friederich","year":"1996","journal-title":"Ann Int Med"},{"key":"10.1111\/jth.12266_bb0315","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","article-title":"Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism","volume":"100","author":"Pabinger","year":"2002","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0320","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism","volume":"20","author":"Brill\u2010Edwards","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12266_bb0325","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy\u2010associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"5","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0330","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2006.06317.x","article-title":"The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis","volume":"3","author":"De Stefano","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12266_bb0335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1160\/TH08-04-0238","article-title":"Recurrent venous thromboembolism after pregnancy\u2010associated versus unprovoked thromboembolism","volume":"2","author":"White","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0340","first-page":"233","article-title":"Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium\u2013a register\u2010based case\u2013control study","volume":"2","author":"Jacobsen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/jth.12266_bb0345","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low\u2010molecular\u2010weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0350","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"11","author":"Lepercq","year":"2001","journal-title":"BJOG"},{"key":"10.1111\/jth.12266_bb0355","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood.V114.22.3132.3132","article-title":"Prevention of venous thromboembolism (VTE) associated with pregnancy in women with a past history of VTE","volume":"114","author":"Rozanski","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0360","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1538-7836.2011.04186.x","article-title":"Prophylaxis with low\u2010dose low\u2010molecular\u2010weight\u2010heparin during pregnancy and postpartum: is it effective?","volume":"9","author":"Roeters van Lennep","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0365","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1600-0412.2011.01098.x","article-title":"Efficacy of obstetric thromboprophylaxis and long\u2010term risk of recurrence of venous thromboembolism","volume":"6","author":"Lindqvist","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/jth.12266_bb0370","first-page":"e000257","volume":"1","author":"Roshani","year":"2011","journal-title":"Risk of early postpartum hemorrhage in women receiving therapeutic doses of low\u2010molecular\u2010weight heparin. BMJ Open"},{"key":"10.1111\/jth.12266_bb0375","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.thromres.2012.03.007","article-title":"The risk of postpartum hemorrhage in women using high dose of low\u2010molecular\u2010weight heparins during pregnancy","volume":"3","author":"Knol","year":"2012","journal-title":"Thromb Res"},{"issue":"Suppl. 1","key":"10.1111\/jth.12266_bb0380","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1538-7836.2007.02501.x","article-title":"Thrombophilia and pregnancy complications: cause or association?","volume":"5","author":"Middeldorp","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0385","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/AOG.0b013e31817e8acc","article-title":"Inherited thrombophilia and pregnancy complications revisited: association not proven causal and antithrombotic prophylaxis is experimental","volume":"2","author":"Rodger","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1111\/jth.12266_bb0390","unstructured":"Lewis, G (ed). The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer \u2010 2003\u20102005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH, 2007."},{"key":"10.1111\/jth.12266_bb0395","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"2","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0400","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1538-7836.2012.04872.x","article-title":"Risk of post\u2010thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study","volume":"10","author":"Chitsike","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0405","first-page":"387","article-title":"The risk of abortion and stillbirth in antithrombin\u2010, protein C\u2010, and protein S\u2010deficient women","volume":"3","author":"Sanson","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0410","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/jth.12266_bb0415","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden mutation","volume":"9","author":"Meinardi","year":"1999","journal-title":"Ann Int Med"},{"key":"10.1111\/jth.12266_bb0420","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta\u2010analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/jth.12266_bb0425","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"2","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12266_bb0430","doi-asserted-by":"crossref","first-page":"e1000292","DOI":"10.1371\/journal.pmed.1000292","article-title":"The association of factor V leiden and prothrombin gene mutation and placenta\u2010mediated pregnancy complications: a systematic review and meta\u2010analysis of prospective cohort studies","volume":"6","author":"Rodger","year":"2010","journal-title":"PLoS Med"},{"key":"10.1111\/jth.12266_bb0435","first-page":"1","article-title":"The investigation and treatment of couples with recurrent first\u2010trimester and second\u2010trimester miscarriage","year":"2011","journal-title":"Green\u2010top Guideline no 17"},{"key":"10.1111\/jth.12266_bb0440","first-page":"CD002859","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","volume":"2","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jth.12266_bb0445","first-page":"2116","article-title":"Evidence\u2010based guidelines for the investigation and medical treatment of recurrent miscarriage","volume":"9","author":"Jauniaux","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1111\/jth.12266_bb0450","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/humrep\/17.2.442","article-title":"Factor V Leiden and recurrent miscarriage\u2010prospective outcome of untreated pregnancies","volume":"2","author":"Rai","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1111\/jth.12266_bb0455","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1538-7836.2007.02586.x","article-title":"Natural course of the subsequent pregnancy after a single loss in women with and without the factor V Leiden or prothrombin 20210A mutations","volume":"5","author":"Coppens","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0460","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0049-3848(11)70028-7","article-title":"Low\u2010molecular\u2010weight heparins have no place in recurrent miscarriage: Debate \u2010 For the motion","volume":"127S","author":"Middeldorp","year":"2011","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12266_bb0465","doi-asserted-by":"crossref","DOI":"10.1093\/humupd\/dmt019","article-title":"Antithrombotic therapy for pregnancy loss","author":"de Jong","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1111\/jth.12266_bb0470","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood-2010-01-267252","article-title":"SPIN: the Scottish Pregnancy Intervention Study: a multicentre randomised controlled trial of low molecular weight heparin and low dose aspirin in women with recurrent miscarriage","volume":"21","author":"Clark","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0475","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"17","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12266_bb0480","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low\u2010molecular\u2010weight heparin versus low\u2010dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0485","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood-2004-06-2121","article-title":"Important publication missing key information","volume":"104","author":"Rodger","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0490","doi-asserted-by":"crossref","unstructured":"Kaandorp SP, Di Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database of Systematic Reviews 2009; Art. No.: CD004734.","DOI":"10.1002\/14651858.CD004734.pub3"},{"key":"10.1111\/jth.12266_bb0495","first-page":"CD006780","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","volume":"6","author":"Dodd","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jth.12266_bb0500","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.0000149950.05182.a3","article-title":"Low\u2010molecular\u2010weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin\u2010converting enzyme DD women","volume":"1","author":"Mello","year":"2005","journal-title":"Hypertension"},{"key":"10.1111\/jth.12266_bb0505","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental\u2010mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"1","author":"Rey","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0510","first-page":"771","article-title":"Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH\u2010AP trial","volume":"4","author":"Gris","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0515","first-page":"1053","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre\u2010eclampsia. The pilot randomised controlled NOH\u2010PE trial","volume":"6","author":"Gris","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0520","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low\u2010molecular\u2010weight heparin added to aspirin in the prevention of recurrent early\u2010onset preeclampsia in women with inheritable thrombophilia: the FRUIT\u2010RCT","volume":"1","author":"de Vries","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0525","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2011-11-391383","article-title":"Heparin in pregnant women with previous placenta\u2010mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial","volume":"14","author":"Martinelli","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0530","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone","volume":"9190","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/jth.12266_bb0535","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"1","author":"Jick","year":"2007","journal-title":"Contraception"},{"issue":"Pt 1","key":"10.1111\/jth.12266_bb0540","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"2","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1111\/jth.12266_bb0545","first-page":"315","volume":"5","year":"1998","journal-title":"Contraception"},{"key":"10.1111\/jth.12266_bb0550","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable DMPA contraceptives or a Levonorgestrel intrauterine device","volume":"11","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12266_bb0555","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow\u2010up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/jth.12266_bb0560","first-page":"CD003552","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","volume":"3","author":"Lopez","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jth.12266_bb0565","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1538-7836.2010.03839.x","article-title":"Hormone replacement therapy and the risk of venous thromboembolism: population\u2010based study","volume":"5","author":"Renoux","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0570","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","article-title":"World distribution of factor V Leiden","volume":"8983","author":"Rees","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/jth.12266_bb0575","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032\u2010untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"10","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0580","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1994.tb04878.x","article-title":"Prevalence of antithrombin deficiency in the healthy population","volume":"1","author":"Tait","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12266_bb0585","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJM198710153171604","article-title":"Absence of thrombosis in subjects with heterozygous protein C deficiency","volume":"16","author":"Miletich","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12266_bb0590","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1365-2141.2001.02813.x","article-title":"A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state","volume":"113","author":"Dykes","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12266_bb0595","first-page":"800","article-title":"Risk of pregnancy\u2010related venous thrombosis in carriers of severe inherited thrombophilia","volume":"3","author":"Martinelli","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12266_bb0600","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2141.2001.02766.x","article-title":"The risk of pregnancy\u2010related venous thromboembolism in women who are homozygous for factor V Leiden","volume":"2","author":"Middeldorp","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12266_bb0605","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1182\/blood-2006-04-016527","article-title":"A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation","volume":"108","author":"Coppens","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0610","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"5","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.12266_bb0615","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2005.01485.x","article-title":"Lupus anticoagulants and the risk of a first episode of deep venous thrombosis","volume":"9","author":"de Groot","year":"2005","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12266","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12266","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622051534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622051534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12266\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:05:52Z","timestamp":1761534352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622051534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":122,"alternative-id":["S1538783622051534"],"URL":"https:\/\/doi.org\/10.1111\/jth.12266","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis in women: what are the knowledge gaps in 2013?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}